The price of Channel Therapeutics Corporation (AMEX:CHRO) shares last traded on Wall Street rose 40.00% to $2.66.
CHRO stock price is now 252.17% away from the 50-day moving average and 146.12% away from the 200-day moving average. The market capitalization of the company currently stands at $16.04M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In other news, Malamut Richard, Director bought 10,400 shares of the company’s stock on Sep 12 ’24. The stock was bought for $9,825 at an average price of $0.94. Upon completion of the transaction, the Director now directly owns 91,565 shares in the company, valued at $0.24 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 13 ’24, CEO, Pres., CFO, Treas & Secty Francis Knuettel II bought 3,500 shares of the business’s stock. A total of $3,395 was incurred on buying the stock at an average price of $0.97. This leaves the insider owning 547,710 shares of the company worth $1.46 million. A total of 70.11% of the company’s stock is owned by insiders.
During the past 12 months, Channel Therapeutics Corporation has had a low of $0.45 and a high of $6.00. The fifty day moving average price for CHRO is $0.71498 and a two-hundred day moving average price translates $1.07992 for the stock.
The latest earnings results from Channel Therapeutics Corporation (AMEX: CHRO) was released for 2024-06-30. The company reported revenue of $2.05 million for the quarter, compared to $1.29 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 58.51 percent.
